BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31532503)

  • 1. Pharmacokinetic considerations in pediatric pharmacotherapy.
    Lim SY; Pettit RS
    Am J Health Syst Pharm; 2019 Sep; 76(19):1472-1480. PubMed ID: 31532503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essentials for starting a pediatric clinical study (1): Pharmacokinetics in children.
    Yokoi T
    J Toxicol Sci; 2009; 34 Suppl 2():SP307-12. PubMed ID: 19571484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Extrapolation of Paracetamol Exposure from Adults to Infants After Oral Administration of a Pediatric Aqueous Suspension Is Highly Dependent on the Study Dosing Conditions.
    Statelova M; Holm R; Fotaki N; Reppas C; Vertzoni M
    AAPS J; 2020 Sep; 22(6):126. PubMed ID: 33000297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of maturation on drug disposition in pediatric patients.
    Stewart CF; Hampton EM
    Clin Pharm; 1987 Jul; 6(7):548-64. PubMed ID: 3319364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics in older persons.
    Cusack BJ
    Am J Geriatr Pharmacother; 2004 Dec; 2(4):274-302. PubMed ID: 15903286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).
    Besunder JB; Reed MD; Blumer JL
    Clin Pharmacokinet; 1988 Apr; 14(4):189-216. PubMed ID: 3292100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing pediatric dosing: a developmental pharmacologic approach.
    Anderson GD; Lynn AM
    Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific features of pharmacokinetics in children.
    Matalová P; Urbánek K; Anzenbacher P
    Drug Metab Rev; 2016; 48(1):70-9. PubMed ID: 26828377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental pharmacokinetics.
    Anderson GD
    Semin Pediatr Neurol; 2010 Dec; 17(4):208-13. PubMed ID: 21183126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing for children: issues in pediatric pharmacology.
    Niederhauser VP
    Nurse Pract; 1997 Mar; 22(3):16-8, 23, 26-8 passim. PubMed ID: 9078512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics in children.
    Routledge PA
    J Antimicrob Chemother; 1994 Aug; 34 Suppl A():19-24. PubMed ID: 7844070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacokinetic standard for babies and adults.
    Holford N; Heo YA; Anderson B
    J Pharm Sci; 2013 Sep; 102(9):2941-52. PubMed ID: 23650116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics in the infant.
    Milsap RL; Jusko WJ
    Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):107-10. PubMed ID: 7737034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid pharmacokinetics in pediatric patients: an overview.
    Jungbluth GL; Welshman IR; Hopkins NK
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S153-7. PubMed ID: 14520140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children.
    Zhou W; Johnson TN; Xu H; Cheung S; Bui KH; Li J; Al-Huniti N; Zhou D
    CPT Pharmacometrics Syst Pharmacol; 2016 Sep; 5(9):475-83. PubMed ID: 27566992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological problems in the management of epilepsy in children.
    Perucca E
    Seizure; 1995 Jun; 4(2):139-43. PubMed ID: 7670766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic changes in critical illness.
    Boucher BA; Wood GC; Swanson JM
    Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of antifungal agents in neonates and young infants.
    Regazzi M; Billaud EM; Lefeuvre S; Stronati M
    Curr Med Chem; 2012; 19(27):4621-32. PubMed ID: 22876899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.